HIV-associated visceral leishmaniasis

Clin Microbiol Infect. 2001 Jun;7(6):291-300. doi: 10.1046/j.1198-743x.2001.00262.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections* / diagnosis
  • AIDS-Related Opportunistic Infections* / drug therapy
  • AIDS-Related Opportunistic Infections* / epidemiology
  • AIDS-Related Opportunistic Infections* / immunology
  • Antiprotozoal Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Leishmaniasis, Visceral* / diagnosis
  • Leishmaniasis, Visceral* / drug therapy
  • Leishmaniasis, Visceral* / epidemiology
  • Leishmaniasis, Visceral* / immunology
  • Prognosis
  • Recurrence
  • Treatment Outcome

Substances

  • Antiprotozoal Agents